Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.

Journal article

Wing PAC. et al, (2023), PLoS pathogens, 19

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis

Journal article

Radford‐Smith DE. et al, (2022), Liver International, 42, 1344 - 1354

Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

Journal article

Goodchild G. et al, (2020), Clinical medicine (London, England), 20, e32 - e39

Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis

Journal article

Cargill T. et al, (2019), Clinical and Translational Gastroenterology, 10, e00020 - e00020